The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Open accessAbstract
Mutations in the gene encoding the transcriptional repressor methyl-CpG binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome. Loss of function as well as increased dosage of the MECP2 gene cause a host of neuropsychiatric disorders. To explore the molecular mechanism(s) underlying these disorders, we examined gene expression patterns in the hypothalamus of mice that either lack or overexpress MeCP2. In both models, MeCP2 dysfunction induced changes in the expression levels of thousands of genes, but unexpectedly the majority of genes (∼85%) appeared to be activated by MeCP2. We selected six genes and confirmed that MeCP2 binds to their promoters. Furthermore, we showed that MeCP2 associates with the transcriptional activator CREB1 at the promoter of an activated target but not a repressed target. These studies suggest that MeCP2 regulates the expression of a wide range of genes in the hypothalamus and that it can function as both an activator and a repressor of transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While Mecp2 mutant mice are an excellent model for RTT, elimination of MeCP2 affects the expression of a profound number of pathways in the CNS, making it difficult to pinpoint which ones play a key role in pathology [77,89,90].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, MeCP2 may also facilitate transcriptional activation [77], chromatin compaction [78,79] and mRNA splicing [80,81], while also interacting with a host of other regulatory proteins involved in a variety of molecular pathways [81–84].”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Altogether, multiple studies suggest that genes can be activated or repressed by MeCP2, depending upon the cellular context [77,89,90], suggesting that MeCP2 may be defined as a transcriptional modulator.”
From Rett syndrome: a neurological disorder with metabolic components (2018) · cites this paper as [77]
In the citing paper
“These data are consistent with another study showing that MeCP2 binding to methylated DNA has a biphasic impact on transcription.”
From Epigenetic mechanisms of major depression: Targeting neuronal plasticity (2018) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Self-citationNan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Zhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Self-citationThe disease progression of Mecp2 mutant mice is affected by the level of BDNF expression
Chang, Q., Khare, G., Dani, V., Nelson, S., & Jaenisch, R. (2006) · Neuron · doi:10.1016/j.neuron.2005.12.027 · Cited by 578
MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number
Chao, H.-T., Zoghbi, H. Y., & Rosenmund, C. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.018 · Cited by 511
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- C. L. Martinet al., Am. J. Med. Genet. B. Neuropsychiatr. Genet.144, 869 (2007).
- H. Caldeira Araujoet al., Am. J. Med. Genet. A.133, 122 (2005).
- We thank members of the Zoghbi laboratory for their thoughtful comments Z. Yin for technical assistance M. Shinawi and A. Tawil for technical advice Y. Klisch for the art work and J. Lim J. Neul and M. Greenberg for reagents. The Baylor College of Medicine Microarray Core Facility performed the microarray experiments. This work was funded by NIH/National Institute of Neurological Disorders and Stroke grant NS057819 (H.Z.) National Institute of Child Health and Human Development Mental Retardation and Developmental Disabilities Research Center HD024064 (H.Z.) the International Rett Syndrome Foundation and the Simons Foundation. H.Z. is a Howard Hughes Medical Institute investigator. The microarray data have been deposited in the National Center for Biotechnology Information Gene Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) and are accessible through GEO Series accession number GSE11150.
Cited by
Sorted by citations
Items 501–600 of 999
Rett Syndrome: From Bed to Bench
Weng, S.-M., Bailey, M. E. S., & Cobb, S. (2011) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2011.08.002 · Cited by 62
A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing
Long, S. W., Ooi, J. Y. Y., Yau, P. M., & Jones, P. L. (2010) · Bioscience Reports · doi:10.1042/bsr20100124 · Cited by 62
The long-term impact of adverse caregiving environments on epigenetic modifications and telomeres
Blaze, J., Asok, A., & Roth, T. L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00079 · Cited by 61
Common Variants on Xq28 Conferring Risk of Schizophrenia in Han Chinese
Wong, E., So, H., Li, M., Wang, Q., Butler, A. W., Paul, B., Wu, H.-M., Hui, T. C. K., Choi, S.-C., So, M., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt104 · Cited by 61
Homberg, J. R., Kyzar, E. J., Scattoni, M. L., Norton, W., Pittman, J. T., Gaikwad, S., Nguyen, M., Poudel, M. K., Ullmann, J. F. P., Diamond, D. M., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.015 · Cited by 67
Tarale, P., Sivanesan, S., Daiwile, A. P., Stöger, R. J., Bafana, A., Naoghare, P. K., Parmar, D., Chakrabarti, T., & Krishnamurthi, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1899-0 · Cited by 62
Ciafrè, S., Ferraguti, G., Greco, A., Polimeni, A., Ralli, M., Ceci, F. M., Ceccanti, M., & Fiore, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.018 · Cited by 64
Kim, K. C., Choi, C. S., Kim, J.-W., Han, S.-H., Cheong, J. H., Ryu, J. H., & Shin, C. Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-8987-z · Cited by 60
Yang, C., van der Woerd, M. J., Muthurajan, U. M., Hansen, J. C., & Luger, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr005 · Cited by 60
The MEF2 family and the brain: from molecules to memory
Dietrich, J. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1565-2 · Cited by 60
Koelsch, K. A., Webb, R. D., Jeffries, M. A., Dozmorov, M. G., Frank, M. B., Guthridge, J. M., James, J. A., Wren, J. D., & Sawalha, A. H. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.012 · Cited by 60
Gangisetty, O., Bekdash, R. A., Maglakelidze, G., & Sarkar, D. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113228 · Cited by 60
Bracaglia, G., Conca, B., Bergo, A., Rusconi, L., Zhou, Z., Greenberg, M. E., Landsberger, N., Soddu, S., & Kilstrup‐Nielsen, C. (2009) · EMBO Reports · doi:10.1038/embor.2009.217 · Cited by 60
Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome
O’Connor, R. D., Zayzafoon, M., Farach‐Carson, M. C., & Schanen, N. C. (2009) · Bone · doi:10.1016/j.bone.2009.04.251 · Cited by 60
Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity
Tarale, P., Chakrabarti, T., Sivanesan, S., Naoghare, P. K., Bafana, A., & Krishnamurthi, K. (2016) · BioMed Research International · doi:10.1155/2016/2548792 · Cited by 63
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
Li, W., Bellot-Saez, A., Phillips, M. L., Yang, T., Longo, F. M., & Pozzo‐Miller, L. D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.029959 · Cited by 59
Bhattacherjee, A., Mu, Y., Winter, M. K., Knapp, J. R., Eggimann, L. S., Gunewardena, S., Kobayashi, K., Kato, S., Krizsan‐Agbas, D., & Smith, P. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618210114 · Cited by 60
Tu, Y.-K., Duman, J. G., & Tolias, K. F. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3461-17.2018 · Cited by 63
Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder
Jeon, S. J., Gonzales, E. L., Mabunga, D. F. N., Valencia, S. T., Kim, D. G., Kim, Y., Adil, K. J., Shin, D., Park, D., & Shin, C. Y. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.321 · Cited by 67
Bridging Rapid and Sustained Antidepressant Effects of Ketamine
Kim, J.-W., Suzuki, K., Kavalali, E. T., & Monteggia, L. M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.02.003 · Cited by 59
Circadian rhythm disruption in a mouse model of Rett syndrome circadian disruption in RTT
Li, Q., Loh, D. H., Kudo, T., Truong, D. A., Derakhshesh, M., Kaswan, Z. A. M., Ghiani, C. A., Tsoa, R. W., Cheng, Y., Sun, Y. E., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.009 · Cited by 60
MicroRNA-Mediated Epigenetic Silencing of Sirtuin1 Contributes to Impaired Angiogenic Responses
Volkmann, I. R., Kumarswamy, R., Pfaff, N., Fiedler, J., Dangwal, S., Holzmann, A., Bátkai, S., Geffers, R., Lother, A., Hein, L., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301702 · Cited by 58
Veeraragavan, S., Wan, Y.-W., Connolly, D. R., Hamilton, S. M., Ward, C. S., Soriano, S., Pitcher, M. R., McGraw, C. M., Huang, S. G., Green, J. R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw178 · Cited by 59
Schlosberg, C., VanderKraats, N. D., & Edwards, J. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx078 · Cited by 52
Yu, B., Yuan, B., Dai, J.-K., Cheng, T.-L., Xia, S.-N., He, L.-J., Yuan, Y.-T., Zhang, Y.-F., Xu, H.-T., Xu, F.-Q., et al. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00467-w · Cited by 58
Neuronal non-CG methylation is an essential target for MeCP2 function
Tillotson, R., Cholewa-Waclaw, J., Chhatbar, K., Connelly, J. C., Kirschner, S. A., Webb, S., Koerner, M. V., Selfridge, J., Kelly, D. A., Sousa, D. D., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.011 · Cited by 56
A brief history of MECP2 duplication syndrome: 20-years of clinical understanding
Ta, D., Downs, J. A., Baynam, G. S., Wilson, A. C., Richmond, P., & Leonard, H. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02278-w · Cited by 61
Sultan, F. A., & Sweatt, J. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8289-5_6 · Cited by 58
Santos, M., Summavielle, T., Teixeira‐Castro, A., Silva‐Fernandes, A., Duarte‐Silva, S., Marques, F., Martins, L., Dierssen, M., Oliveira, P., Sousa, N., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.010 · Cited by 57
Miguet, M., Faivre, L. O., Amiel, J., Nizon, M., Touraine, R. L., Prieur, F., Pasquier, L., Lefebvre, M., Thévenon, J., Dubourg, C., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104956 · Cited by 58
How alcohol drinking affects our genes: an epigenetic point of view
Ciafrè, S., Carito, V., Ferraguti, G., Greco, A., Chaldakov, G. N., Fiore, M., & Ceccanti, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0248 · Cited by 64
Perineuronal net degradation rescues CA2 plasticity in a mouse model of Rett syndrome
Carstens, K. E., Lustberg, D. J., Shaughnessy, E. K., McCann, K. E., Alexander, G. M., & Dudek, S. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci137221 · Cited by 57
MECP2 genomic structure and function: insights from ENCODE
Singh, J., Saxena, A., Christodoulou, J., & Ravine, D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn591 · Cited by 60
Loss of MeCP2 function is associated with distinct gene expression changes in the striatum
Zhao, Y.-T., Goffin, D., Johnson, B. S., & Zhou, Z. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.001 · Cited by 59
Maddox, S. A., Schafe, G. E., & Ressler, K. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00062 · Cited by 60
Cognitive deficits in Rett syndrome: What we know and what we need to know to treat them
Berger-Sweeney, J. E. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.05.006 · Cited by 59
MicroRNAs in addiction: adaptation's middlemen?
Li, M. D., & van der Vaart, A. D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.58 · Cited by 57
Synaptic determinants of Rett syndrome
Boggio (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00028 · Cited by 59
Epigenetic Modification of the Norepinephrine Transporter Gene in Postural Tachycardia Syndrome
Bayles, R., KN, H., Lambert, E., Baker, E. K., Agrotis, A., Guo, L., Jowett, J. B. M., Esler, M., Lambert, G., & El-Osta, A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244343 · Cited by 56
Chehadeh, S. E., Touraine, R. L., Prieur, F., Reardon, W., Bienvenu, T., Chantot‐Bastaraud, S., Doco‐Fenzy, M., Landais, E., Philippe, C., Marle, N., et al. (2016) · Clinical Genetics · doi:10.1111/cge.12898 · Cited by 56
Tong, D., Zhang, J., Wang, X., Li, Q., Liu, L. Y., Yang, J., Guo, B., Ni, L., Zhao, L., & Huang, C. Y. (2020) · Oncogenesis · doi:10.1038/s41389-020-0239-7 · Cited by 53
Roux, J., Dura, E., & Villard, L. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.045 · Cited by 56
Mechanisms and therapeutic challenges in autism spectrum disorders
Castro, J. E., Mellios, N., & Sur, M. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835f19a7 · Cited by 53
Forlani, G., Giarda, E., Ala, U., Cunto, F. D., Salani, M., Tupler, R. G., Kilstrup‐Nielsen, C., & Landsberger, N. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq214 · Cited by 56
Sen, N. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8306-x · Cited by 58
Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and Plasticity
Duman, J. G., Tu, Y.-K., & Tolias, K. F. (2016) · Neural Plasticity · doi:10.1155/2016/8301737 · Cited by 56
Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome
Peters, S. U., Fu, C., Suter, B., Marsh, E. D., Benke, T. A., Skinner, S. A., Lieberman, D. N., Standridge, S. M., Jones, M. D., Beisang, A., et al. (2019) · Clinical Genetics · doi:10.1111/cge.13521 · Cited by 55
Mechanisms for Cognitive Impairment in Epilepsy: Moving Beyond Seizures
Khalife, M. R., Scott, R. C., & Hernan, A. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.878991 · Cited by 59
MeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation
Li, C., Jiang, S., Liu, S.-Q., Lykken, E. A., Zhao, L., Sevilla, J., Zhu, B., & Li, Q.-J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401505111 · Cited by 57
Kerr, B., Jessica Soto, C., Sáez, M., Abrams, A. J., Walz, K., & Young, J. I. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.145 · Cited by 55
Theoharides, T. C., Athanassiou, M. C., Panagiotidou, S., & Doyle, R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.12.003 · Cited by 56
Ju, A., Hammerschmidt, K., Tantra, M., Krueger‐Burg, D., Brose, N., & Ehrenreich, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.019 · Cited by 56
Degano, A. L., Pasterkamp, R. J., & Ronnett, G. V. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.07.009 · Cited by 56
Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts
He, Y., Tsou, P., Khanna, D., & Sawalha, A. H. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213022 · Cited by 55
Epigenetics-based therapeutics for myocardial fibrosis
Li, X., Yang, Y., Chen, S., Zhou, J., Li, J., & Cheng, Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119186 · Cited by 55
Small regulatory RNAs in neurodevelopmental disorders
Chang, S., Wen, S., Chen, D., & Jin, P. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp072 · Cited by 59
Cheng, J., Huang, M., Zhu, Y. J., Xin, Y., Zhao, Y., Huang, J. J., Yu, J., Zhou, W., & Qiu, Z. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12523 · Cited by 54
The role of genetics in the establishment and maintenance of the epigenome
Huidobro, C., Fernández, A. F., & Fraga, M. F. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1296-2 · Cited by 55
Stoyanova, E. I., Riad, M. H., Rao, A., & Heintz, N. (2021) · eLife · doi:10.7554/elife.66973 · Cited by 57
Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA
Reautschnig, P., Fruhner, C., Wahn, N., Wiegand, C. P., Kragness, S., Yung, J. F., Hofacker, D. T., Fisk, J. R., Eidelman, M., Waffenschmidt, N., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02313-0 · Cited by 54
Role of Microbiome in Regulating the HPA Axis and Its Relevance to Allergy
Sudo, N. (2012) · Chemical Immunology and Allergy · doi:10.1159/000336510 · Cited by 54
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice
Stagni, F., Giacomini, A., Guidi, S., Ciani, E., Ragazzi, E., Filonzi, M., IASIO, R. D., Rimondini, R., & Bartesaghi, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.005 · Cited by 55
Grayson, D. R., Chen, Y., Dong, E., Kundaković, M., & Guidotti, A. (2009) · Epigenetics · doi:10.4161/epi.4.3.8534 · Cited by 54
Pini, G., Congiu, L., Benincasa, A., DiMarco, P., Bigoni, S., Dyer, A. H., Mortimer, N., Della-Chiesa, A., O’Leary, S. T., McNamara, R., et al. (2016) · Autism Research and Treatment · doi:10.1155/2016/5073078 · Cited by 55
Glaucoma related Proteomic Alterations in Human Retina Samples
Funke, S., Perumal, N., Gehrke-Beck, S., Gabel-Scheurich, S., Schmelter, C., Teister, J., Gerbig, C., Gramlich, O. W., Pfeiffer, N., & Grus, F. H. (2016) · Scientific Reports · doi:10.1038/srep29759 · Cited by 54
Sbardella, D., Tundo, G. R., Campagnolo, L., Valacchi, G., Orlandi, A., Curatolo, P., Borsellino, G., D’Esposito, M., Ciaccio, C., Cesare, S. D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12069-0 · Cited by 55
Zhu, Y., Huang, M., Bushong, E. A., Phan, S., Uytiepo, M., Beutter, E., Boemer, D., Tsui, K. C., Ellisman, M. H., & Maximov, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11409-0 · Cited by 54
Cerebral organoids as tools to identify the developmental roots of autism
Chan, W. K., Griffiths, R., Price, D. J., & Mason, J. O. (2020) · Molecular Autism · doi:10.1186/s13229-020-00360-3 · Cited by 58
Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant Action
Hutchinson, A. N., Deng, J. V., Cohen, S., & West, A. E. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2156-12.2012 · Cited by 53
MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion
Ibrahim, A., Papin, C., Mohideen-Abdul, K., Gras, S. L., Stoll, I., Bronner, C., Dimitrov, S. I., Klaholz, B. P., & Hamiche, A. (2021) · Science · doi:10.1126/science.abd5581 · Cited by 53
Chromatin context and ncRNA highlight targets of MeCP2 in brain
Maxwell, S., Pelka, G. J., Tam, P., & El‐Osta, A. (2013) · RNA Biology · doi:10.4161/rna.26921 · Cited by 56
Qiang, M., Denny, A. D., Chen, J., Ticku, M. K., Yan, B., & Henderson, G. I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008798 · Cited by 53
The Genetic and Epigenetic Journey of Embryonic Stem Cells into Mature Neural Cells
Olynik, B. M., & Rastegar, M. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00081 · Cited by 58
Maddox, S. A., Watts, C. S., & Schafe, G. E. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.11.008 · Cited by 54
Why schizophrenia genetics needs epigenetics: a review.
Marić, N. P., & Švrakić, D. M. (2012) · PubMed · Cited by 53
X-Chromosome Inactivation in Rett Syndrome Human Induced Pluripotent Stem Cells
Cheung, A. Y. L., Horvath, L. M., Carrel, L., & Ellis, J. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00024 · Cited by 56
Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons
Sampathkumar, C., Wu, Y.-J., Vadhvani, M., Trimbuch, T., Eickholt, B. J., & Rosenmund, C. (2016) · eLife · doi:10.7554/elife.19374 · Cited by 53
Landucci, E., Brindisi, M., Bianciardi, L., Catania, L. M., Daga, S., Croci, S., Frullanti, E., Fallerini, C., Butini, S., Brogi, S., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.001 · Cited by 57
Brain-Derived Neurotrophic Factor and Rett Syndrome
Katz, D. M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_18 · Cited by 53
Smolen, P., Baxter, D. A., & Byrne, J. H. (2019) · Learning & Memory · doi:10.1101/lm.049395.119 · Cited by 56
In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system
de León‐Guerrero, S. D., Pedraza‐Alva, G., & Pérez‐Martínez, L. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07658.x · Cited by 53
Epigenetic mechanisms impacted by chronic stress across the rodent lifespan
Dion, A., Muñoz, P., & Franklin, T. B. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100434 · Cited by 54
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
Vuu, Y. M., Roberts, C.-T., & Rastegar, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044218 · Cited by 55
Vecsler, M., Zeev, B. B., Nudelman, I., Anikster, Y., Simon, A. J., Amariglio, N., Rechavi, G., Baasov, T., & Gak, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020733 · Cited by 52
Leoh, L. S., van Heertum, B., Rijck, J. D., Filippova, M., Ríos-Colón, L., Basu, A., Martinez, S. R., Tungteakkhun, S. S., Filippov, V., Christ, F., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0314 · Cited by 52
Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development
Alvarez-Saavedra, M., Carrasco, L., Sura‐Trueba, S., Aiello, V. D., Walz, K., Neto, J. X., & Young, J. I. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq096 · Cited by 52
Does microglial dysfunction play a role in autism and Rett syndrome?
Maezawa, I., Calafiore, M., Wulff, H., & Jin, L. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x1200004x · Cited by 53
Ludwig, A. K., Zhang, P., & Cardoso, M. C. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00115 · Cited by 56
Kokare, D. M., Kyzar, E. J., Zhang, H., Sakharkar, A. J., & Pandey, S. C. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx041 · Cited by 54
The Expanding Therapeutic Potential of Neuronal KCC2
Tang, B. L. (2020) · Cells · doi:10.3390/cells9010240 · Cited by 52
Regulation of GABAA Receptor Subunit Expression in Substance Use Disorders
Barker, J., & Hines, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124445 · Cited by 54
Segatto, M., Tonini, C., Pfrieger, F. W., Trezza, V., & Pallottini, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133317 · Cited by 51
Microdeletion 5q14.3 and anomalies of brain development
Hotz, A., Hellenbroich, Y., Sperner, J., Linder-Lucht, M., Tacke, U., Walter, C., Caliebe, A., Nagel, I., Saunders, D. E., Wolff, G., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36020 · Cited by 51
Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action
Bedogni, F., Rossi, R. L., Galli, F., Cobolli Gigli, C., Gandaglia, A., Kilstrup-Nielsen, C., & Landsberger, N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.01.011 · Cited by 51
Williamson, S. L., Giudici, L., Kilstrup‐Nielsen, C., Gold, W. A., Pelka, G. J., Tam, P., Grimm, A. J., Prodi, D. A., Landsberger, N., & Christodoulou, J. (2011) · Human Genetics · doi:10.1007/s00439-011-1058-x · Cited by 51
Romano‐López, A., Méndez‐Díaz, M., Ruiz‐Contreras, A. E., Carrisoza‐Gaytan, R., & Prospero-Garcia, O. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.071 · Cited by 53
Dynamic DNA methylation controls glutamate receptor trafficking and synaptic scaling
Sweatt, J. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13564 · Cited by 52
BDNF-TrkB signalling in fear learning: from genetics to neural networks
Musumeci, G., & Minichiello, L. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.031 · Cited by 51
DNA methylation signatures: Biomarkers of drug and alcohol abuse
Mahna, D., Puri, S., & Sharma, S. (2018) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2018.06.002 · Cited by 51
Metadata
- Authors
- Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Zoghbi, Huda Y.
- Venue
- Science
- Published
- 2008-05-30
- Volume
- 320
- Issue
- 5880
- Pages
- 1224-1229
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2443785
- OpenAlex
- W2039276157
- Cited by
- 1,823
- References
- 22
- Citations by year
- 2026: 53 · 2025: 55 · 2024: 76 · 2023: 67 · 2022: 84 · 2021: 95 · 2020: 96 · 2019: 90 · 2018: 69 · 2017: 131 · 2016: 133 · 2015: 113 · 2014: 131 · 2013: 153 · 2012: 128
- FWCI
- 66.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of Neurological Disorders and Stroke (NS057819, R01NS057819)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 024064, P30HD024064)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MeCP2, Rett syndrome, transcriptional repression, transcriptional activation, CREB1, promoter binding, hypothalamus, gene expression profiling, neuropsychiatric disorders, neurodevelopmental disorders
- MeSH terms
- Animals, Disease Models, Animal, Gene Expression Regulation, Hypothalamic Diseases, Hypothalamus, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Nervous System Diseases, Protein Binding, Repressor Proteins, Transcription Factors, Rett Syndrome, Transcriptional Activation, Cyclic AMP Response Element-Binding Protein, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice, Methyl-CpG-Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
